Edition:
United Kingdom

Arbutus Biopharma Corp Says On March 13, Koert Vandenenden, Announced Intention To Resign As Chief Accounting Officer - SEC Filing


Friday, 15 Mar 2019 

March 15 (Reuters) - Arbutus Biopharma Corp ::ARBUTUS BIOPHARMA CORP SAYS ON MARCH 13, KOERT VANDENENDEN, ANNOUNCED INTENTION TO RESIGN AS CHIEF ACCOUNTING OFFICER - SEC FILING.ARBUTUS BIOPHARMA CORP SAYS DAVID HASTINGS, COMPANY’S CFO, HAS BEEN APPOINTED AS COMPANY’S PRINCIPAL ACCOUNTING OFFICER. 

Company Quote

1.5
0.08 +5.63%
16 Aug 2019